analyst
FT
NASDAQ · FTRE
Fortrea Holdings Inc.
Healthcare · Biotechnology
$19.73
Up+$0.24 (+1.22%)
Updated Sep 16, 2026, 10:48 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.4B
- P/E ratio
- -1.4
- Dividend yield
- 0.00%
- 52-week range
- $8.31 – $21.39
- Volume
- 1.95M
- Avg. volume
- 1.34M
Price performance
FTRE price history
1M range · 20 trading sessions · Daily adjusted prices
FTRE closed at $19.73 after 20 trading sessions, up 12.10% for the selected period.
- Last close
- $19.73
- Period change
- +12.10%
- Period low
- $16.79
- Period high
- $19.73
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $17.21 | $19.915 | $17.155 | $19.73 | 1.95M |
| Sep 14, 2026 | $17.22 | $17.67 | $16.98 | $17.41 | 2M |
| Sep 11, 2026 | $17.10 | $17.57 | $16.84 | $17.20 | 1.43M |
| Sep 10, 2026 | $16.36 | $17.03 | $16.0717 | $17.02 | 741.16K |
| Sep 9, 2026 | $16.86 | $17.09 | $16.70 | $16.79 | 1.24M |
| Sep 8, 2026 | $17.28 | $17.61 | $16.86 | $17.06 | 1.52M |
| Sep 4, 2026 | $18.50 | $18.50 | $17.64 | $17.70 | 762.08K |
| Sep 3, 2026 | $18.67 | $18.99 | $18.18 | $18.62 | 776.31K |
| Sep 2, 2026 | $17.91 | $19.00 | $17.81 | $18.36 | 902.45K |
| Sep 1, 2026 | $18.38 | $18.51 | $17.62 | $17.72 | 1.19M |
| Aug 31, 2026 | $18.60 | $18.77 | $18.02 | $18.37 | 1.51M |
| Aug 28, 2026 | $18.765 | $19.14 | $18.46 | $18.81 | 1.14M |
| Aug 27, 2026 | $18.70 | $19.34 | $18.55 | $18.86 | 1.32M |
| Aug 26, 2026 | $18.10 | $18.55 | $17.99 | $18.53 | 598.3K |
| Aug 25, 2026 | $18.33 | $18.64 | $17.87 | $18.27 | 599.53K |
| Aug 24, 2026 | $18.34 | $18.45 | $17.78 | $18.31 | 1.05M |
| Aug 21, 2026 | $18.23 | $18.539 | $17.82 | $18.39 | 864.12K |
| Aug 20, 2026 | $17.88 | $18.765 | $17.87 | $18.19 | 1.52M |
| Aug 19, 2026 | $17.93 | $18.49 | $17.8675 | $18.14 | 1.03M |
| Aug 18, 2026 | $17.80 | $18.10 | $17.405 | $17.60 | 682.08K |
Latest FTRE news
The latest Smart Investors Daily articles mentioning FTRE.
Stock researchCompany · Overview
Loading stock research…

